Results 131 to 140 of about 85,533 (259)

Porphyromonas gingivalis GroEL accelerates abdominal aortic aneurysm formation by matrix metalloproteinase‐2 SUMOylation in vascular smooth muscle cells: A novel finding for the activation of MMP‐2

Molecular Oral Microbiology, EarlyView.
Abstract Infection is a known cause of abdominal aortic aneurysm (AAA), and matrix metalloproteases‐2 (MMP‐2) secreted by vascular smooth muscle cells (SMCs) plays a key role in the structural disruption of the middle layer of the arteries during AAA progression.
Yi‐Wen Lin, Feng‐Yen Lin, Ze‐Hao Lai, Chien‐Sung Tsai, Yi‐Ting Tsai, Yen‐Sung Huang, Chen‐Wei Liu   +6 more
wiley   +1 more source

Social inequalities in the misbelief of chloroquine's protective effect against COVID-19: results from the EPICOVID-19 study in Brazil. [PDF]

PLoS One
Nunes BP, Crochemore-Silva I, Mielke GI, Vidaletti LP, Mesenburg MA, da Silveira MF, Hallal PC.   +6 more
europepmc   +1 more source

NEMO‐NDAS: Case Report and Review of the Literature

Pediatric Dermatology, EarlyView.
ABSTRACT NEMO‐deleted exon 5 autoinflammatory syndrome (NEMO‐NDAS) is the result of a gain‐of‐function IKBKG pathogenic variant leading to dysregulated NF‐κB signaling and systemic inflammation. We present a case of NEMO‐NDAS in a 2‐year‐old female presenting with recurrent fevers, subcutaneous nodules, lymphadenopathy, and splenomegaly.
Angela Yang, Kristie Mar, Kimberly A. Morishita, Kevin Meesters, Antonio Torrelo, Joseph M. Lam   +5 more
wiley   +1 more source

Antiviral Activity of Essential Oil from <i>Populus balsamifera</i> L. Buds and Its Major Compounds Against Betacoronavirus HCoV-OC43 Using a Sensitive Cytoprotection Assay. [PDF]

Molecules
Girard L, Côté H, Pichette A, Savard J, Ripoll L, Legault J.   +5 more
europepmc   +1 more source

Risk of Serious Adverse Events and Death With Low‐Dose Methotrexate Versus Hydroxychloroquine in Adults Receiving Dialysis

Seminars in Dialysis, EarlyView.
ABSTRACT Background Several case reports have linked low‐dose methotrexate to serious adverse events, including death, in dialysis patients. We compared the risk of serious adverse events in dialysis patients initiating low‐dose methotrexate versus hydroxychloroquine.
Flory T. Muanda, Peter G. Blake, Matthew A. Weir, Fatemeh Ahmadi, Mohammad Ali Omrani, Sheikh S. Abdullah, Eric McArthur, Jessica M. Sontrop, Brad L. Urquhart, Amit X. Garg   +9 more
wiley   +1 more source

Evaluation of the Antimalarial Potential of a Combination of <i>Terminalia macroptera</i> and <i>Erythrina sigmoidea:</i> In Vitro and In Silico Assays. [PDF]

J Parasitol Res
Sandra TNJ, Nadia NAC, Cedric Y, Guy-Armand GN, Sidiki NNA, Azizi MA, Payne VK, Hu H.   +7 more
europepmc   +1 more source

Hydroxychloroquine Patch Test Positivity in a Patient With Systemic Lupus Erythematosus

Contact Dermatitis, EarlyView.
Alexa G. Ries, Zachary Frost, Zachary Hopkins, Jamie P. Schlarbaum   +3 more
wiley   +1 more source

Strong Cross‐Reactivity of Anti–Plasmodium falciparum pLDH Monoclonal Antibodies With Plasmodium malariae pLDH in the Abbott Bioline Malaria Ag P.f/P.f/P.v Rapid Diagnostic Test

Tropical Medicine &International Health, EarlyView.
ABSTRACT Objectives This study aimed to describe the cross‐reactivity of the Abbott Bioline Malaria Ag P.f/P.f/P.v rapid diagnostic test, designed to detect Plasmodium falciparum and P. vivax, with other Plasmodium species, based on the detection of parasite lactate dehydrogenase enzymes.
Gabriel Montoia, Maria Carmen Arroyo Sanchez, Giselle Lima‐Cooper, Maria de Lourdes Rego Neves Farinas, Juliana Inoue, Silvia Maria Di Santi   +5 more
wiley   +1 more source

Hepatorenal protective role of encapsulated <i>Holothuria atra</i> in a mice model of <i>Plasmodium berghei</i> ANKA inoculation. [PDF]

J Adv Vet Anim Res
Utami PD, Setianingsih H, Sari DRT.
europepmc   +1 more source

Short‐Course Low‐Dose Primaquine for Radical Cure in G6PD‐Normal Patients in the Pre‐Elimination Context of Nepal

Tropical Medicine &International Health, EarlyView.
ABSTRACT Background Plasmodium vivax remains a challenge for malaria elimination in Nepal due to its ability to relapse. Radical cure with primaquine is effective but limited by poor adherence to the standard 14‐day low‐dose regimen. In 2022, the WHO recommended administering the same total dose (3.5 mg/kg) over 7 days to improve adherence.
Prakash Ghimire, Gokarna Dahal, Nabaraj Adhikari, Komal Raj Rijal, Sanjib Adhikari, Megha Raj Banjara, Hellen Mnjala, Grant Lee, Sophie Weston, Angela Rumaseb, Anjana Rai, Benedikt Ley, Mohammad Sharif Hossain, Julie A. Simpson, Megha Rajasekhar, Bipin Adhikari, Ric N. Price, Bibek K. Lal, Kamala Thriemer   +18 more
wiley   +1 more source